666

LUMOSA THERAPEUTICS CO LTD

No trades
See on Supercharts
Market capitalization
‪32.40 B‬TWD
‪−238.04 M‬TWD
‪56.92 M‬TWD
‪117.46 M‬
Beta (1Y)
−0.10

About LUMOSA THERAPEUTICS CO LTD

CEO
Jung Chin Lin
Headquarters
Taipei
Employees (FY)
47
Founded
2000
ISIN
TW0006535008
FIGI
BBG009KDN2S9
Lumosa Therapeutics Co., Ltd. is a drug development company, which engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. It operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6535 is 181.5 TWD — it has decreased by 4.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange LUMOSA THERAPEUTICS CO LTD stocks are traded under the ticker 6535.
LUMOSA THERAPEUTICS CO LTD is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6535 stock is 9.48% volatile and has beta coefficient of −0.10. Check out the list of the most volatile stocks — is LUMOSA THERAPEUTICS CO LTD there?
One year price forecast for LUMOSA THERAPEUTICS CO LTD has a max estimate of 228.0 TWD and a min estimate of 228.0 TWD.
Yes, you can track LUMOSA THERAPEUTICS CO LTD financials in yearly and quarterly reports right on TradingView.
6535 stock has fallen by 7.40% compared to the previous week, the month change is a 2.54% rise, over the last year LUMOSA THERAPEUTICS CO LTD has showed a 335.25% increase.
6535 net income for the last quarter is ‪−112.51 M‬ TWD, while the quarter before that showed ‪−119.92 M‬ TWD of net income which accounts for 6.18% change. Track more LUMOSA THERAPEUTICS CO LTD financial stats to get the full picture.
Today LUMOSA THERAPEUTICS CO LTD has the market capitalization of ‪30.78 B‬, it has increased by 13.12% over the last week.
No, 6535 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6535 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUMOSA THERAPEUTICS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
6535 reached its all-time high on Apr 9, 2024 with the price of 233.5 TWD, and its all-time low was 21.0 TWD and was reached on Mar 23, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 47.00 employees. See our rating of the largest employees — is LUMOSA THERAPEUTICS CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUMOSA THERAPEUTICS CO LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUMOSA THERAPEUTICS CO LTD stock shows the buy signal. See more of LUMOSA THERAPEUTICS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LUMOSA THERAPEUTICS CO LTD future price: according to them, 6535 price has a max estimate of 228.00 TWD and a min estimate of 228.00 TWD. Read a more detailed LUMOSA THERAPEUTICS CO LTD forecast: see what analysts think of LUMOSA THERAPEUTICS CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUMOSA THERAPEUTICS CO LTD EBITDA is ‪−352.42 M‬ TWD, and current EBITDA margin is −619.19%. See more stats in LUMOSA THERAPEUTICS CO LTD financial statements.